The "Alpha 1 Antitrypsin Deficiency Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Alpha 1 Antitrypsin Deficiency Treatment Market to Reach $2.9 Billion by 2027
Amid the COVID-19 crisis, the global market for Alpha 1 Antitrypsin Deficiency Treatment estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 8.9% over the analysis period 2020-2027.
Augmentation Therapy, one of the segments analyzed in the report, is projected to record a 9.7% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bronchodilator segment is readjusted to a revised 9.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $463.6 Million, While China is Forecast to Grow at 8.3% CAGR
The Alpha 1 Antitrypsin Deficiency Treatment market in the U.S. is estimated at US$463.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$493.1 Million by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.4% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.
Corticosteroids Segment to Record 7.7% CAGR
In the global Corticosteroids segment, USA, Canada, Japan, China and Europe will drive the 7.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$189.6 Million in the year 2020 will reach a projected size of US$319.9 Million by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$328.4 Million by the year 2027.
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS (Total 46 Featured):
Abeona Therapeutics Inc.
Applied Genetic Technologies Corporation
Arrowhead Pharmaceuticals Inc.
Baxter International, Inc.
Boehringer Ingelheim International GmbH
Chiesi Farmaceutici SpA
Grifols International SA
ProMetic Life Sciences, Inc.
Teva Pharmaceutical Industries Ltd.
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Rest Of Europe
Rest Of Asia-Pacific
Rest Of Latin America
United Arab Emirates
Rest Of Middle East
Total Companies Profiled: 46
For more information about this report visit https://www.researchandmarkets.com/r/f89cy3
View source version on businesswire.com: https://www.businesswire.com/news/home/20210420005918/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900